Effect of withania somnifera dunal root extract against pentylenetetrazol seizure threshold in mice: Possible involvement of GABAergic system

Indian Journal of Experimental Biology

Volumn 46, Issue 6, 2008, Pages 465-469

  Kulkarni, S K ^a   Akula, Kiran Kumar ^a   Dhir, Ashish ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Diazepam; Gaba; Pentylenetetrazol; Seizure threshold; Withania somnifera

Indexed keywords

MUS; WITHANIA SOMNIFERA;

4 AMINOBUTYRIC ACID A RECEPTOR; ANTICONVULSIVE AGENT; PLANT EXTRACT;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; MALE; MOUSE; PHYTOTHERAPY; PLANT ROOT; SEIZURE; WITHANIA;

ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; MALE; MICE; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; RECEPTORS, GABA-A; SEIZURES; WITHANIA;

EID: 50349100599     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Sharma S, Dahanukar S & Karandikar S M, Effects of long term administration of the roots of ashwagandha (Withania somnifera) and shatavari (Asparagus racemosus) in rats, Indian Drugs, 23 (1985) 133.
2. Vaidyaratnam P S Varier's, Indian medicinal plants, A compendium of 500 species, (edited by PK Warrier, VPK Nambiar, Ramakutty) part II (Orient Longman Publications, Hyderabad) 1994, 52.
3. Mohan R, Hammers H J, Bargagna-Mohan P, Zhan X H, Herbstritt C J, Ruiz A, Zhang L, Hanson A D, Conner B P, Rougas J & Pribluda V S, Withaferin A is a potent inhibitor of angiogenesis, Angiogenesis, 7 (2004) 115.
4. Rai D, Bhatia G, Sen T & Palit G, Anti-stress effects of Ginkgo biloba and Panax ginseng a comparative study, J Pharmacol Sci, 93 (2003) 458.
5. Winters M, Ancient medicine, modern use: Withania somnifera and its potential role in integrative oncology, Altern Med Rev, 11 (2006) 269.
6. Rasool M & Varalakshmi P, Immunomodulatory role of Withania somnifera root powder on experimental induced inflammation: An in vivo and in vitro study, Vascul Pharmacol, 44 (2006) 406.
7. Bhattacharya S K, Satyan K S & Ghosal S, Antioxidant activity of glycowithanolides from Withania somnifera, Indian J Exp Biol, 35 (1997) 236.
8. Naidu P S, Singh A & Kulkarni S K, Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction, Phytother Res, 20 (2006) 140.
9. Bhattacharya A, Ghosal S & Bhattacharya S K, Anxiolyticantidepressant activity of Withania somnifera glycowithanolides: An Experimental study, Phytomedicine, 7 (2000) 463.
10. Dhuley J N, Nootropic-like effect of ashwagandha (Withania somnifera L.) in mice, Phytother Res, 15 (2001) 524.
11. Jain S, Shukla S D, Sharma K & Bhatnagar M, Neuroprotective effects of Withania somnifera Dunn. in hippocampal sub-regions of female albino rat, Phytother Res, 15 (2001) 544.
12. Singh A, Naidu P S, Gupta S & Kulkarni S K, Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome, J Med Food, 5 (2002) 211.
13. Kumar A & Kulkarni S K, Effect of BR-16A (Mentat), a polyherbal formulation on drug-induced catalepsy in mice, Indian J Exp Biol, 44 (2006) 45.
14. Kulkarni S K & Dhir A, Withania somnifera: An Indian ginseng, Prog Neuropsychopharmacol Biol Psychiatry, (2007) (in press).
15. Lö scher W, Hö nack D, Fassbender C P & Nolting B, The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazol seizure models, Epilepsy Res, 8 (1991) 171.
16. Kulkarni S K & Verma A, GABA receptor mediated anticonvulsant action of Withania somnifera root extract, Indian Drugs, 30 (1993) 305.
17. Mehta A K, Binkley P, Gandhi S S & Ticku M K, Pharmacological effects of Withania somnifera root extract on GABAA receptor complex, Indian J Med Res, 94 (1991) 312.
18. Akula K K, Dhir A, Bishnoi M & Kulkarni S K, Effect of systemic administration of adenosine on brain adenosine levels in pentylenetetrazol- induced seizure threshold in mice, Neurosci. Lett, 425 (2007) 39.
19. Akula K K, Dhir A & Kulkarni S K, Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor increases pentylenetetrazol seizure threshold in mice: Possible involvement of adenosinergic mechanism, Epilepsy Res, 78 (2008) 60.
20. Ramanjaneyulu R & Ticku M K, Interactions of pentamethylenetetrazole and tetrazole analogues with the picrotoxinin site of the benzodiazepine-GABA receptorionophore complex, Eur J Pharmacol, 98 (1984) 337.
21. Ray A B & Gupta M, Withasteroids, a growing group of naturally occurring steroidal lactones, Prog Chem Org Nat Prod, 63 (1994) 1.
22. Kulkarni S K & Verma A, Prevention of development of tolerance and dependence to opiate in mice by BR-16A (Mentat), a herbal psychotropic preparation, Indian J Exp Biol, 30 (1992) 885.
23. Kulkarni S K & George B, Anticonvulsant action of Withania somnifera (Ashwagandha) root extract against pentylenetetrazolinduced kindling in mice, Phytother Res, 10 (1996) 447.
24. Kulkarni S K & George B, Amygdaloid kindling in rats: Protective effect of Withania somnifera (Ashwagandha) root extract, Indian Drugs, 32 (1995) 37.
25. Kulkarni S K, George B & Mathur R, Neuroprotection by Withania somnifera root extract against lithium-pilocarpineinduced seizures, Indian Drugs, 35 (1998) 208.
26. Dhir A, Naidu P S & Kulkarni S K, Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)-induced convulsions: Possible mechanism of action, Prog Neuropsychopharmacol Biol Psychiatry, 30 (2006) 1478.
27. Sieghart W, GABAA receptors: Ligand-gated Cl- ion channels modulated by multiple drug-binding sites, Trends Pharmacol Sci, 13 (1992) 446.
28. Smith G B & Olsen C E, Functional domains of GABAA receptors, Trends Pharmacol Sci, 16 (1995) 162.
29. David M, GABAergic mechanism in epilepsy, Epilepsia, 42 (2001) 8.